Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.
about
LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein levelPolymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapyGenetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.Comparison of false-discovery rate for genome-wide and fine mapping regions.Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans.LPA and PLG sequence variation and kringle IV-2 copy number in two populations.Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.Lipoprotein (a): structure, pathophysiology and clinical implications.Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresisLipoprotein(a): an emerging cardiovascular risk factor.Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic riskApolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinomaApolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrationsLipoprotein(a): an elusive cardiovascular risk factor5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients.Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humansSerum Lp(a) lipoprotein concentration and outcome of thrombolytic treatment for myocardial infarction.Scavenger receptor-BI is a receptor for lipoprotein(a).A Case-Control Study of the Relationship Between SLC22A3-LPAL2-LPA Gene Cluster Polymorphism and Coronary Artery Disease in the Han Chinese Population.Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis.The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.Lipoprotein (a). Heterogeneity and biological relevance.Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region.Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles.Interaction of recombinant apolipoprotein(a) and lipoprotein(a) with macrophages.Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.Lipoprotein (a): genetic marker for atherosclerosis?Distribution of apolipoprotein(a) isoforms in normotensive and severe preeclamptic women.Differences between genotyping and phenotyping methods for assessing apolipoprotein(a) size polymorphisms.
P2860
Q28144616-8BAE0F2D-2B1F-41AD-8B92-7C5EDCF043DFQ28293224-C85B6DC7-51AF-4820-B96F-047D0AC5A90CQ30497894-0D0CB471-5C54-41FA-8C4A-F15F02139253Q33332860-09D60E0B-9AEF-4905-8C50-B2D2B4B2D733Q33808934-B58FB090-293F-4657-A836-3489711F3AD7Q33818108-DE5C677C-B18D-48BF-96B6-48003084D621Q33896318-1F07F358-A86A-4042-BF04-C542D69E133DQ34020677-310B1603-B798-45D0-A452-64B3DD4D2499Q34265255-67BD04EE-9111-45F2-A3BC-E906E8FA9363Q35081894-C17F4E6D-3844-40A2-934E-1365F8E68FD3Q35575772-BCDF5AD1-31C8-4038-A2F1-6B0825DDB1DBQ35599857-30EFAC9A-E818-4F48-9F7B-941C806A079CQ35600471-6D7DD576-0327-4278-B83E-EC07FF1CC942Q35603379-3EDB6A67-0FE5-45BC-AFEF-0C074A993797Q35746190-546C6B43-0AF7-45EE-BE21-35FB124DEC6CQ36104114-F1298363-9555-4C62-B90A-C8374E8E35BBQ36449485-F5713C6F-03DD-4BEC-9AEF-97021BAD5D47Q36617508-72E18C82-55CF-40BE-A083-70D65C8CDC45Q36812940-9029325D-0F4B-4FD1-8719-04777320284DQ37076505-036A61B1-4CD8-45C5-BC19-9F85EF6898D1Q37231203-4B099213-2B82-4778-ADD0-2D0F745EEF83Q37401506-D66DE96F-39B3-42BF-BF1F-6F8A1CE09B45Q37442363-85C757E6-4013-40FF-AE3A-79BE5FF9A7D3Q37853403-85A5EB13-CCE0-49CC-BD25-8C2E7AA29E66Q39781234-4EB92B51-B161-4B6E-B3BF-596C1BDB0989Q40154290-123C2759-0689-439D-BA41-3235844DEE62Q40335473-46C8580D-CEF5-4EE4-AEB9-29C41456536FQ40512049-4996675F-1E2C-4F6B-B3DC-1EE9AC7ADBD1Q40716232-74A8F73F-9025-4454-9EF5-C282EB67A344Q41878504-B32C8BBD-5E0A-4921-A81F-82A382596CB7Q46355764-67FDB817-1E6A-4B8D-AFBF-39EDD4AE5CDEQ47438941-5B015F25-C7F8-48DD-91E6-353713AC7565
P2860
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
Plasma Ip
@nl
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@ast
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@en
type
label
Plasma Ip
@nl
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@ast
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@en
prefLabel
Plasma Ip
@nl
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@ast
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@en
P2093
P2860
P356
P1476
Plasma Ip(a) concentration is ...... ng domains in the apo(a) gene.
@en
P2093
P2860
P304
P356
10.1172/JCI114395
P407
P577
1989-12-01T00:00:00Z